Mubritinib-HSA Binding: Molecular Insights for Drug Delivery
2026-07-07
This article reviews the recent study on mubritinib’s binding to human serum albumin (HSA), highlighting its mechanistic characterization via spectroscopy and molecular docking. These findings clarify how mubritinib’s pharmacokinetics and protein-induced alterations impact its utility as an anti-proliferative agent, offering direct implications for cancer drug development and experimental design.
Pioglitazone as a PPARγ Agonist: Applied Workflows and Insig
2026-07-06
Pioglitazone, a selective PPARγ agonist, empowers researchers to dissect metabolic and inflammatory pathways in cellular and animal models. This guide delivers step-by-step workflows, troubleshooting strategies, and practical insights—bridging the latest macrophage polarization research with robust lab execution.
Substance P in Applied Neuroimmunology: Workflow & Troublesh
2026-07-06
Unlock the full experimental power of Substance P in dissecting pain, inflammation, and immune pathways with protocol-driven workflows. This guide translates cutting-edge fluorescence analytics and neurokinin signaling insights into lab-ready strategies, spotlighting APExBIO’s high-purity Substance P for reproducible and precision-driven research.
Optimizing Protein Extraction with NP-40 Lysis Buffer (SKU K
2026-07-05
This scenario-driven article addresses real laboratory challenges in cell and tissue lysis, focusing on how NP-40 Lysis Buffer (SKU K1127) supports reproducible, high-quality protein extraction for downstream assays. Through evidence-backed Q&A, we demonstrate how this non-denaturing lysis buffer from APExBIO improves workflow reliability and experimental outcomes.
MK-4827 (Niraparib): Spliceosome-Driven PARP Inhibitor Sensi
2026-07-04
Explore how MK-4827 (Niraparib) reveals new frontiers in cancer research by targeting DNA repair and spliceosome regulation. Learn how recent discoveries in hepatocellular carcinoma expand the utility of this selective PARP inhibitor.
Optimized hGBA1 mRNA Restores Lysosomal Function in Gaucher
2026-07-03
This study demonstrates that rationally engineered human GBA1 mRNA, delivered via lipid nanoparticles, can markedly enhance β-glucocerebrosidase (GCase) expression and lysosomal targeting in both cell and animal models of Gaucher disease. The findings position mRNA-LNP therapy as a promising alternative to enzyme replacement, with significant implications for lysosomal storage disorder research.
Dimetridazole: Mechanisms, Evidence, and Workflow in Antimic
2026-07-03
Dimetridazole (1,2-Dimethyl-5-nitroimidazole) is a validated quorum sensing inhibitor with potent activity against anaerobic bacteria and protozoa. It disrupts membrane integrity, suppresses virulence, and potentiates β-lactam efficacy, as confirmed in multidrug-resistant E. coli models. Its robust chemical profile and synergy data make it a cornerstone for modern antimicrobial and infection model research.
O-GlcNAcylation in Wnt-Stimulated Osteogenesis: Mechanisms U
2026-07-02
This article summarizes new evidence that O-GlcNAcylation is essential for Wnt-driven bone formation via metabolic reprogramming of osteoblasts. The findings clarify key molecular events linking Wnt signaling to aerobic glycolysis and osteogenesis, with implications for bone disease research and experimental modulation strategies.
Silybin A: Precision Silymarin for Liver and Metabolic Resea
2026-07-02
Silybin A, a key flavonolignan from silymarin, exhibits potent hepatoprotective and antioxidant actions. Its validated purity and selectivity make it indispensable for liver disease and metabolic enzyme modulation studies. This dossier details its mechanisms, evidence, and research protocols.
CBD Alleviates Orofacial Inflammatory Pain via Cannabinoid a
2026-07-01
This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective dimensions of orofacial inflammatory pain in mouse models. The work highlights coordinated modulation of the endocannabinoid and serotonergic systems, suggesting CBD’s translational potential for managing pain and its emotional comorbidities.
Perphenazine: Advanced Mechanistic Insights for Neuropharmac
2026-07-01
Discover how Perphenazine, a potent dopamine D2 receptor antagonist, enables innovative research at the intersection of neuropharmacology and host-directed antibacterial strategies. This article delivers advanced mechanistic insights and practical guidance not found in existing overviews.
Innovations in Firefly Luciferase mRNA: Stability, Delivery
2026-06-30
Explore the scientific advances of Firefly Luciferase mRNA with 5-moUTP modification, featuring APExBIO's EZ Cap™ technology. This article uniquely dissects delivery stability, innate immune suppression, and assay optimization, providing researchers with actionable insights beyond standard workflows.
Troglitazone as a PPARγ Agonist: Enhanced Protocols in Tumor
2026-06-30
Troglitazone, a dual PPARγ/α agonist, empowers researchers to dissect and manipulate metabolic and immuno-oncologic pathways in both cellular and animal models. This article details practical protocols, troubleshooting insight, and the translational edge Troglitazone offers for targeting lipid/glucose metabolism and tumor-associated macrophages.
Dimetridazole: Advanced Protocols for Multidrug-Resistant Pa
2026-06-29
Dimetridazole (1,2-Dimethyl-5-nitroimidazole) unlocks new avenues for combating multidrug-resistant bacteria by synergizing with β-lactam antibiotics and disrupting microbial membrane integrity. Harness its versatility for quorum sensing inhibition, biofilm suppression, and robust infection model studies, with actionable workflow tips for reproducible results.
Radicicol: A Potent Hsp90 Inhibitor for Cellular and Inflamm
2026-06-29
Radicicol is a highly selective Hsp90 inhibitor with nanomolar potency that modulates adipogenesis and enhances apoptosis in cancer cells. It also exhibits anti-inflammatory effects in vivo, particularly in sepsis models. This article provides a mechanistic and evidence-based overview for researchers using Radicicol in advanced cell biology workflows.
464 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page